Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease

PhotoSENSIL-18 assay development: Enhancing the safety testing of cosmetic raw materials and finished products to support the in vitro photosensitization assessment?

Toxicology·2023

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study.

Annals of hematology·2023

[Diabetes and frailty in the elderly. A prospective study of an outpatient population supported by general practitioners].

Revue medicale de Liege·2021

[Type 2 diabetes and the elderly : a real problem].

Revue medicale de Liege·2021

[The practice of telemedicine by French internal medicine physicians in 2019].

La Revue de medecine interne·2021

[Characteristics of patients admitted from emergency units in 18 internal medicine departments and organisation of these departments: A cross sectional study from SNFMI (SiFMI study group) in 2015].

La Revue de medecine interne·2020

Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

The inflammation-immunosuppression loop as a driver of immune dysfunction and secondary infections in severe COVID-19.

Frontiers in immunology·2026

A neutrophil-to-lymphocyte ratio-centered machine learning model for predicting immunotherapy response in esophageal squamous cell carcinoma patients.

Journal of thoracic disease·2026

Association between the systemic immune-inflammation index and overall survival in patients with leukemia: a multicenter cohort study.

Translational cancer research·2026

IL-18 in atherosclerosis: context-dependent biology, human evidence, and translational challenges.

Frontiers in cardiovascular medicine·2026

Determinants of intensive care unit-acquired acute brain injury in acute respiratory distress syndrome: a retrospective cohort study of ventilator settings and patient factors.

Journal of thoracic disease·2026

Research trends and cellular targets of NF-κB pathway in acute lung injury [2005-2024]: a combined bibliometric analysis and systematic review.

Journal of thoracic disease·2026

Related Experiment Videos

Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease

Related Concept Videos

PhotoSENSIL-18 assay development: Enhancing the safety testing of cosmetic raw materials and finished products to support the in vitro photosensitization assessment?

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study.

[Diabetes and frailty in the elderly. A prospective study of an outpatient population supported by general practitioners].

[Type 2 diabetes and the elderly : a real problem].

[The practice of telemedicine by French internal medicine physicians in 2019].

[Characteristics of patients admitted from emergency units in 18 internal medicine departments and organisation of these departments: A cross sectional study from SNFMI (SiFMI study group) in 2015].

Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.

Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.

Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

The inflammation-immunosuppression loop as a driver of immune dysfunction and secondary infections in severe COVID-19.

A neutrophil-to-lymphocyte ratio-centered machine learning model for predicting immunotherapy response in esophageal squamous cell carcinoma patients.

Association between the systemic immune-inflammation index and overall survival in patients with leukemia: a multicenter cohort study.

IL-18 in atherosclerosis: context-dependent biology, human evidence, and translational challenges.

Determinants of intensive care unit-acquired acute brain injury in acute respiratory distress syndrome: a retrospective cohort study of ventilator settings and patient factors.

Research trends and cellular targets of NF-κB pathway in acute lung injury [2005-2024]: a combined bibliometric analysis and systematic review.

Related Experiment Videos

Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease

Related Concept Videos

Related Articles